Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 68419-38-5 | MDL No. : | MFCD08461073 |
Formula : | C7H15NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PTHDBHDZSMGHKF-SSDOTTSWSA-N |
M.W : | 129.20 | Pubchem ID : | 1715108 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 41.53 |
TPSA : | 32.26 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.82 cm/s |
Log Po/w (iLOGP) : | 1.83 |
Log Po/w (XLOGP3) : | 0.38 |
Log Po/w (WLOGP) : | 0.13 |
Log Po/w (MLOGP) : | 0.57 |
Log Po/w (SILICOS-IT) : | 1.23 |
Consensus Log Po/w : | 0.83 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.75 |
Solubility : | 23.1 mg/ml ; 0.178 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.62 |
Solubility : | 30.8 mg/ml ; 0.238 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.28 |
Solubility : | 6.7 mg/ml ; 0.0519 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 787622-24-6 ]
(R)-2-(Piperidin-2-yl)ethanol hydrochloride
Similarity: 0.96
[ 786684-21-7 ]
(S)-2-(2-Hydroxyethyl)piperidine hydrochloride
Similarity: 0.96
[ 1215020-95-3 ]
2-(Piperidin-2-yl)ethanol hydrochloride
Similarity: 0.96
[ 538-09-0 ]
(3-endo)-8-Azabicyclo[3.2.1]octan-3-ol
Similarity: 0.88
[ 787622-24-6 ]
(R)-2-(Piperidin-2-yl)ethanol hydrochloride
Similarity: 0.96
[ 786684-21-7 ]
(S)-2-(2-Hydroxyethyl)piperidine hydrochloride
Similarity: 0.96
[ 538-09-0 ]
(3-endo)-8-Azabicyclo[3.2.1]octan-3-ol
Similarity: 0.88
[ 1185088-10-1 ]
2-(2-Methoxyethyl)piperidine hydrochloride
Similarity: 0.85
[ 17366-48-2 ]
exo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride
Similarity: 0.85
[ 787622-24-6 ]
(R)-2-(Piperidin-2-yl)ethanol hydrochloride
Similarity: 0.96
[ 786684-21-7 ]
(S)-2-(2-Hydroxyethyl)piperidine hydrochloride
Similarity: 0.96
[ 1215020-95-3 ]
2-(Piperidin-2-yl)ethanol hydrochloride
Similarity: 0.96
[ 1185088-10-1 ]
2-(2-Methoxyethyl)piperidine hydrochloride
Similarity: 0.85